Bach, Trusheim, Sen. Cassidy outline scheme for subscription-based purchasing

Peter Bach, Mark Trusheim and Sen. Bill Cassidy (R-La.) outlined a model for states to use as a basic reference point when implementing a subscription-based drug payment model for HCV drugs like the one proposed by Louisiana. The recommendations were published in a viewpoint article in Journal of the American Medical Association on Monday.

Bach is director of Memorial Sloan Kettering Cancer Center’s Center for Health Policy and Outcomes and chair of CMS's Medicare Evidence Development & Coverage Advisory Committee. Trusheim is strategic director of Massachusetts Institute of Technology's NEW Drug Development ParadIGmS (NEWDIGS)...